REPLIMUNE GROUP INC (REPL)

NASDAQ — Healthcare: Manufacturing, Biotechnology: Biological Products (No Disgnostic Substances)

replimune.com

Upcoming Events

Jul 22, 2025, 5:00:00 AM

PDUFA Date for RP1

The FDA has set a PDUFA date of July 22, 2025, for Replimune's RP1, a significant milestone in the regulatory process for this oncolytic immunotherapy.

fda decision